{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T06:14:04Z","timestamp":1662790444837},"reference-count":24,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.9931","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T11:40:55Z","timestamp":1547466055000},"source":"Crossref","is-referenced-by-count":0,"title":["Metachronous bilateral triple\u2011negative breast cancer associated with neurofibromatosis type 1: A case report"],"prefix":"10.3892","author":[{"given":"Yoji","family":"Yamagishi","sequence":"first","affiliation":[{"name":"Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Einama","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamio","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Koiwai","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Hiratsuka","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Fukumura","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359\u20118513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"key20200714085542_b1-ol-0-0-9931","first-page":"1657","article-title":"Diagnostic criteria and treatment guidelines for nerve fibrosis type 1 (Recklinghausen's disease)","volume":"118","author":"Yoshida","year":"2008","journal-title":"Jpn J Dermatol"},{"key":"key20200714085542_b2-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"key20200714085542_b3-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","article-title":"Neurofibromatosis Type 1 and tumorigenesis: Molecular mechanisms and therapeutic implications","volume":"28","author":"Gottfried","year":"2010","journal-title":"Neurosurg Focus"},{"key":"key20200714085542_b4-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","article-title":"Malignancy in neurofibromatosis type 1","volume":"5","author":"Korf","year":"2000","journal-title":"Oncologist"},{"key":"key20200714085542_b5-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/bjc.2016.403","article-title":"Breast cancer in neurofibromatosis type 1: Overrepresentation of unfavourable prognostic factors","volume":"116","author":"Uusitalo","year":"2017","journal-title":"Br J Cancer"},{"key":"key20200714085542_b6-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/gyno.2002.6757","article-title":"BRCA1-related malignancies in a family presenting with von recklinghausen's disease","volume":"86","author":"Ceccaroni","year":"2002","journal-title":"Gynecol Oncol"},{"key":"key20200714085542_b7-ol-0-0-9931","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714085542_b8-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20200714085542_b9-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: Recommendations from the international Ki67 in breast cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key20200714085542_b10-ol-0-0-9931","article-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017","edition":"8th"},{"key":"key20200714085542_b11-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12282-009-0119-7","article-title":"Breast cancer associated with type 1 neurofibromatosis","volume":"17","author":"Salemis","year":"2010","journal-title":"Breast Cancer"},{"key":"key20200714085542_b12-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"key":"key20200714085542_b13-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00220540","article-title":"Genetics of neurofibromatosis 1 in Japan: Mutation rate and paternal age effect","volume":"89","author":"Takano","year":"1992","journal-title":"Hum Genetics"},{"key":"key20200714085542_b14-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM198604173141603","article-title":"Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms","volume":"314","author":"Sorensen","year":"1986","journal-title":"N Engl J Med"},{"key":"key20200714085542_b15-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Zoller","year":"1997","journal-title":"Cancer"},{"key":"key20200714085542_b16-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","article-title":"Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening","volume":"44","author":"Sharif","year":"2007","journal-title":"J Med Genet"},{"key":"key20200714085542_b17-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","article-title":"A prospective study of neurofibromatosis type 1 cancer incidence in the UK","volume":"95","author":"Walker","year":"2006","journal-title":"Br J Cancer"},{"key":"key20200714085542_b18-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","article-title":"Increased risk of breast cancer in women with NF1","volume":"158a","author":"Madanikia","year":"2012","journal-title":"Am J Med Genet A"},{"key":"key20200714085542_b19-ol-0-0-9931","first-page":"3","article-title":"Breast cancer associated with Recklinghausen's disease: Report of a case","volume":"67","author":"Nakamura","year":"1998","journal-title":"Nihon Geka Hokan"},{"key":"key20200714085542_b20-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02967173","article-title":"T1 Breast cancer associated with von recklinghausen's neurofibromatosis","volume":"6","author":"Murayama","year":"1999","journal-title":"Breast Cancer"},{"key":"key20200714085542_b21-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"key20200714085542_b22-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4048\/jbc.2015.18.1.97","article-title":"Early-onset breast cancer in a family with neurofibromatosis type 1 associated with a germline mutation in BRCA1","volume":"18","author":"Jeon","year":"2015","journal-title":"J Breast Cancer"},{"key":"key20200714085542_b23-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-013-2538-6","article-title":"Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer","volume":"139","author":"Campos","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20200714085542_b24-ol-0-0-9931","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN Guidelines insights: Genetic\/familial high-risk assessment: Breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:37:47Z","timestamp":1662788267000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.9931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.9931","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]}}}